FILTER BY:
Details
Olaparib in Patients With HRD Malignant Mesothelioma
Address: 5700 S Maryland Ave, Chicago, IL 60637, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: True
- Peritoneal: True
- Pericardial: True
- Tunica Vaginalis: True
Type: Epitheliod, Biphasic, Sarcomatoid
Condition: Mesothelioma, Homologous Recombination Deficiency
Description: In this study, researchers will give olaparib (a drug) to mesothelioma patients who have specific changes in their DNA (known as gene mutations). Researchers will give this drug to each patient on the study to find out if it will help the patient's tumor shrink or stop growing.
Research Center: University of Chicago Medicine
Treatment Interventions: DRUG: Olaparib
Potential Impact: High
Clinical Trial Number: NCT04515836
Phase: Phase 2
Status:
